Professor Mohammad Najlah
Professor Mohammad Najlah provides scientific leadership and direction to GMPriority Pharma, shaping the company’s approach to delivery science, formulation design and real-world translation.
Professor Mohammad Najlah
BPharm, PgDip, PhD, FHEA, CChem, FRSC
Chief Scientist & Co-Founder
Professor Najlah’s work spans academic research, translational delivery science and industrial collaboration, with a focus on lipid-based and liposomal systems.
His research centres on understanding how delivery architectures behave across:
⇒ formulation
⇒ processing
⇒ scale-up
providing scientific insight that translates into systems which can be manufactured, characterised and applied reliably.
At GMPriority Pharma, this directly informs a delivery-first approach where systems are designed with real-world constraints in mind from the outset.
Advancing delivery architectures
Professor Najlah
Academic and professional appointments
- Professor of Pharmaceutics & Nanomedicine
- Lead, Pharmaceutical Research Group, MTRC, ARU
- Fellow of the Royal Society of Chemistry (FRSC)
- Fellow of the Higher Education Academy (FHEA)
- Board Member, Academy of Pharmaceutical Sciences
Professor Najlah’s work extends beyond conventional liposomal design into the exploration of advanced delivery structures and processing strategies.
This includes:
Ξ Investigation of non-conventional and inverted liposomal systems
Ξ Development of controlled particle engineering approaches
Ξ Translation of novel delivery concepts into scalable, manufacturable formats
with elements of this work contributing to:
Ξ Proprietary formulation strategies
Ξ Protected process methodologies
Ξ Ongoing intellectual property development
From research to real-world application
Alongside his role at GMPriority Pharma, Professor Najlah holds an academic appointment and has led or contributed to multiple publicly funded research programmes focused on delivery system design, characterisation and translation.
These programmes have included collaborations supported by Innovate UK and European funding initiatives, addressing challenges such as:
- Liposomal system design and optimisation
- Structural and physicochemical characterisation
- Scale-up and manufacturing translation
Rather than existing in parallel, this work directly informs platform development:
Scientifically rigorous
Technically validated
Grounded in manufacturing reality
Professor Najlah’s broader research contributions include work in lipid-based delivery systems for therapeutic applications, including areas such as controlled drug delivery and oncology-focused systems.
Bridging research and application
Professor Najlah’s role extends beyond scientific discovery into the deliberate translation of research insight into delivery architectures that can be applied consistently across ingredients, formulations and commercial pathways.
His work focuses on understanding how delivery systems behave under:
Real formulation conditions
Processing environments
Scale-up constraints
shaping systems that remain robust outside controlled laboratory settings.
Delivery systems should not be defined by novelty alone,
but by their ability to perform reliably beyond the laboratory,across manufacture,
regulation and market deployment.
Scientific stewardship
As Chief Scientist and Co-Founder, Professor Najlah acts as scientific steward of GMPriority Pharma’s delivery platforms, guiding their evolution with clarity, discipline and long-term intent.
This ensures delivery science is not developed in isolation, but governed across research, formulation, manufacturing and commercial application
Academic collaboration, publicly funded research and industry engagement are integrated deliberately – not as parallel activities, but as inputs into platform design and validation.
